Leadership

• CTO & COO, Eutilex (KOSDAQ listed)
• CEO & Board of Directors, NanoEnTek (KOSDAQ listed)
• Senior Vice President, SK Telecom (KOSPI listed)
• CEO, Kim Laboratories, Inc.

Dr. Kim received his B.S. in Microbiology, M.S. in Biology, and Ph.D. in Microbiology from the University of Illinois at Urbana-Champaign.
He also received MBA from the University of Chicago Booth School of Business.

• Chair Professor, KAIST (Korean Advanced Institute of Science & Technology)
• Professor, Dept. of Biological Science, KAIST
• Professor, GIST (GwangJu Institute of Science and Technology)
• Post-doc, MIT (under Prof. Robert Langer)
• Post-doc, POSTECH (under Prof. Kimoon Kim, Recipient of Hoam Award in 2006)
• Publications >150 papers (Over 16,000 citations, h-index: 55), Patents >90 cases, 10 Tech. transfer cases
• Associations: American Institute of Medical and Biological Engineering Fellow, Most Citation Award (2015), The Distinguished Lectureship Award (2014), U.S. Nanomedicine Society Young Scientist Award (2007), Editorial Board Member in ChemMedChem, Theranostics

Dr. Jon received his B.S, M.S., and Ph.D. in Chemistry from KAIST.

• EVP, Eutilex (as the head of the GMP Facility, Medical Development Center, R&D Center, and GCLP Laboratory)
• Chief, Immune Cell Production Unit, National Cancer Center
• Research Scientist, R&D Center for Cancer Therapeutics, National Cancer Center
• Research Scientist, Immunomodulation Research Center
• Extensive experience in the fields of Infectious/Inflammatory diseases, Autoimmune diseases, and Cancers
• Publications 39 papers, Patents 7 cases

Dr. Kim received his Ph.D. in Immunology and Biomedicine from the University of Ulsan.

• Financial Advisory, Deloitte Hong Kong
• Financial Advisory, Deloitte Korea
• Operation Manager, MoFE Indonesia

Duk holds B.A. from Korea University and M.B.A. from the University of Chicago.